PDS Planning’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
PDS Planning's NVO Position: Q1 2026 in Review
PDS Planning reduced its Novo Nordisk (NVO) stake by 40% in Q1 2026, selling an estimated $274K and leaving 8,587 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #380.
PDS Planning first reported a position in NVO in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.77M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- PDS Planning held 8,587 shares of Novo Nordisk worth $316K as of Q1 2026.
- PDS Planning sold 5,789 Novo Nordisk shares in Q1 2026, an estimated $274K.
- Novo Nordisk made up 0.02% of PDS Planning's portfolio in Q1 2026, its #380 holding.
- PDS Planning first reported a position in Novo Nordisk in Q2 2021 and has held it in 20 quarters since.
- PDS Planning's Novo Nordisk position peaked at $1.77M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.